Stay updated with breaking news from Next Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Guardant Health (NASDAQ:GH – Free Report) had its target price cut by Morgan Stanley from $55.00 to $50.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have an overweight rating on the stock. GH has been the subject of a number of other research reports. The Goldman Sachs Group dropped […]
Mackenzie Financial Corp acquired a new stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 6,978 shares of the company’s stock, valued at approximately $247,000. Several other hedge funds have also recently bought and sold shares […]
Guardant Health (NASDAQ:GH – Free Report) had its price objective cut by Morgan Stanley from $55.00 to $50.00 in a report released on Wednesday, Benzinga reports. They currently have an overweight rating on the stock. Several other research firms have also weighed in on GH. Citigroup reiterated a buy rating and issued a $50.00 price […]
Bfsg LLC bought a new stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 22,676 shares of the company’s stock, valued at approximately $812,000. Other hedge funds and other institutional investors […]
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have received a consensus recommendation of “Buy” from the fourteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Fourteen research analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have covered the stock in […]